Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05447650 · ClinicalTrials.gov registry record · NA
Microcurrent Stimulation Therapy for Nonexudative Age-related Macular Degeneration (i-SIGHT)
A NA study of Age-related Macular Degeneration and Dry Age-Related Macular Degeneration, sponsored by i-Lumen Scientific.
- Completed
- Registry status
- NA
- Development phase
- 95
- Enrollment target
- 10
- Study locations
NCT05447650 is a NA study of Age-related Macular Degeneration and Dry Age-Related Macular Degeneration that has completed, run by i-Lumen Scientific. The registered enrollment target is 95 participants, below the 1,506-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (94% lower). The trial reports 10 study locations across 6 states.
The verdict
NCT05447650, a NA study of Age-related Macular Degeneration and Dry Age-Related Macular Degeneration, has completed, sponsored by i-Lumen Scientific.
- COMPLETED
- Registry status
- NA
- Development phase
- 95 participants
- Enrollment target
- 10
- Study locations
Study Summary
Evaluate the safety and efficacy of transpalpebral microcurrent stimulation (MCS) therapy for patients with nonexudative (dry) age-related macular degeneration (AMD).
Conditions Studied
Interventions
- DEVICE i-Lumen(TM) AMD
- DEVICE i-Lumen(TM) AMD Sham
Study Locations (10)
Texas
- Austin Research Center for Retina - Austin
- Retina Consultants of Texas - Bellaire
- Star Retina - Burleson
- Texas Retina Associates - Fort Worth
Pennsylvania
- Cumberland Valley Retina Consultants - Chambersburg
- Erie Retina Research, LLC - Erie
Arizona
- Associated Retina Consultants - Phoenix
California
- Bay Area Retina Associates - Walnut Creek
Illinois
- University Retina and Macula Associates, PC - Lemont
Tennessee
- Charles Retina Institute - Germantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2022-04-12 |
| Est. Completion | 2025-06-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05447650
The ClinicalTrials.gov registry entry for NCT05447650 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,506-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (94% lower). The listed sponsor is i-Lumen Scientific, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Age-related Macular Degeneration appearing as the primary indexed condition, and to 2 interventions - of which i-Lumen(TM) AMD is the first listed.
NCT05447650 reports 10 study locations spanning 6 distinct geographic areas - top geographies include Texas, Pennsylvania, Arizona.
Frequently Asked Questions
What is clinical trial NCT05447650 about?
NCT05447650 is a clinical study titled "Microcurrent Stimulation Therapy for Nonexudative Age-related Macular Degeneration (i-SIGHT)". Evaluate the safety and efficacy of transpalpebral microcurrent stimulation (MCS) therapy for patients with nonexudative (dry) age-related macular degeneration (AMD).
What is the current status of trial NCT05447650?
This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2022-04-12. Estimated completion is 2025-06-15.
What conditions does trial NCT05447650 study?
This clinical trial studies the following conditions: Age-related Macular Degeneration, Dry Age-Related Macular Degeneration, Nonexudative Age-related Macular Degeneration.
What interventions are being tested in trial NCT05447650?
The interventions under investigation include: i-Lumen(TM) AMD (DEVICE), i-Lumen(TM) AMD Sham (DEVICE).
Who is sponsoring clinical trial NCT05447650?
This trial is sponsored by i-Lumen Scientific, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05447650 being conducted?
This trial has 10 study locations across Arizona, California, Illinois, Pennsylvania, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Age-related Macular Degeneration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Visual Remapping to Aid Reading With Field Loss
RECRUITING · NA
-
Effects of Goji vs. Fiber on Macular Degeneration
RECRUITING · NA
-
Lutein, Zeaxathin, and Fish Oil Supplementation
RECRUITING · NA
-
Stem Cell Ophthalmology Treatment Study II
RECRUITING · NA
-
Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
RECRUITING · NA
Explore more on PlainTrial
Age-related Macular Degeneration
All registered trials for this condition
Dry Age-Related Macular Degeneration
All registered trials for this condition
Arizona
All trials with a study site in Arizona
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.